Wellnex Life Ltd

Wellnex Life Ltd's next confirmed earnings release is scheduled for March 4, 2027.

As of June 30, 2024, Wellnex Life Ltd has 28.46M shares outstanding.

As of June 30, 2024, Wellnex Life Ltd maintains a current ratio of 0.35, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 148.52, indicating elevated leverage, while an interest coverage ratio of -4.23 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2024, Wellnex Life Ltd posted a negative return on equity (ROE) of -379.04, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -64.63, reflecting losses generated across the asset base. Inventory turnover of 3.79 indicates how many times Wellnex Life Ltd sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 22, 2026, Wellnex Life Ltd's stock has declined approximately 60.00% over the past 52 weeks. The 50-day moving average sits at 5.48, while the 200-day moving average is 6.12.

Over the twelve months ended June 30, 2024, Wellnex Life Ltd generated 893.55M in revenue and converted that into -777.72M in net income, yielding earnings per share of -41.44. EBITDA reached -534.33M, while operating income came in at -340.60M.

As of June 30, 2024, Wellnex Life Ltd holds 47.65M in cash and equivalents against 562.93M in total debt, resulting in a net debt position of 512.53M. Total book value stands at 379.02M, with working capital of -942.00M providing operational flexibility.

Over the twelve months ended June 30, 2024, Wellnex Life Ltd posted a gross margin of 29.96, reflecting its pricing power and cost economics. The operating margin of -38.12 and net profit margin of -87.04 provide insight into operational efficiency.

Wellnex Life Ltd's most recent stock split took place on February 12, 2025 with a 29:32 split ratio.